Concepedia

Publication | Closed Access

Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial.

19

Citations

0

References

1996

Year

N.C. Tassopoulos, G. Karvountzis, Giota Touloumi, J. Delladetsima, George Papatheodoridis, A. Katsoulidou, G. Retalis, A. Hatzakis
PubMed

Abstract

1) A larger dose of IFN-alpha does not improve the sustained response rate; however, it may be of benefit in early stages of chronic hepatitis C. 2) Pretreatment, histological stage, and possibly HCV genotype appear to be the main prognostic factors of sustained response.